|
Document And Entity Information (USD $)
In Millions, except Share data, unless otherwise specified |
12 Months Ended | ||
|---|---|---|---|
|
Sep. 30, 2011
|
Dec. 15, 2011
|
Mar. 31, 2011
|
|
| Document And Entity Information [Abstract] | |||
| Document Type | 10-K | ||
| Amendment Flag | false | ||
| Document Period End Date | Sep. 30, 2011 | ||
| Document Fiscal Period Focus | FY | ||
| Document Fiscal Year Focus | 2011 | ||
| Entity Registrant Name | ARROWHEAD RESEARCH CORP | ||
| Entity Central Index Key | 0000879407 | ||
| Current Fiscal Year End Date | --09-30 | ||
| Entity Filer Category | Smaller Reporting Company | ||
| Entity Common Stock, Shares Outstanding | 10,525,941 | ||
| Entity Well-known Seasoned Issuer | No | ||
| Entity Public Float | $ 53 | ||
| Entity Current Reporting Status | Yes | ||
| Entity Voluntary Filers | No |
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
If the value is true, then the document as an amendment to previously-filed/accepted document. No definition available.
|
| X | ||||||||||
|
- Definition
End date of current fiscal year in the format --MM-DD. No definition available.
|
| X | ||||||||||
|
- Definition
This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY. No definition available.
|
| X | ||||||||||
|
- Definition
This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006. No definition available.
|
| X | ||||||||||
|
- Definition
The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD. No definition available.
|
| X | ||||||||||
|
- Definition
The type of document being provided (such as 10-K, 10-Q, N-1A, etc). The document type is limited to the same value as the supporting SEC submission type, minus any "/A" suffix. The acceptable values are as follows: S-1, S-3, S-4, S-11, F-1, F-3, F-4, F-9, F-10, 6-K, 8-K, 10, 10-K, 10-Q, 20-F, 40-F, N-1A, 485BPOS, 497, NCSR, N-CSR, N-CSRS, N-Q, 10-KT, 10-QT, 20-FT, POS AM and Other. No definition available.
|
| X | ||||||||||
|
- Definition
A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Indicate number of shares outstanding of each of registrant's classes of common stock, as of latest practicable date. Where multiple classes exist define each class by adding class of stock items such as Common Class A [Member], Common Class B [Member] onto the Instrument [Domain] of the Entity Listings, Instrument No definition available.
|
| X | ||||||||||
|
- Definition
Indicate "Yes" or "No" whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
| X | ||||||||||
|
- Definition
Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, or (4) Smaller Reporting Company. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure. No definition available.
|
| X | ||||||||||
|
- Definition
State aggregate market value of voting and non-voting common equity held by non-affiliates computed by reference to price at which the common equity was last sold, or average bid and asked price of such common equity, as of the last business day of registrant's most recently completed second fiscal quarter. The public float should be reported on the cover page of the registrants form 10K. No definition available.
|
| X | ||||||||||
|
- Definition
The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Indicate "Yes" or "No" if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. No definition available.
|
| X | ||||||||||
|
- Definition
Indicate "Yes" or "No" if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A. No definition available.
|
| X | ||||||||||
|
- Definition
Research equipment. No definition available.
|
| X | ||||||||||
|
- Definition
Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cumulative amount of depreciation, depletion and amortization (related to property, plant and equipment, but not including land) that has been recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The gross amount of capitalized computer software costs as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Includes currency on hand as well as demand deposits with banks or financial institutions. It also includes other kinds of accounts that have the general characteristics of demand deposits in that the Entity may deposit additional funds at any time and also effectively may withdraw funds at any time without prior notice or penalty. Cash equivalents, excluding items classified as marketable securities, include short-term, highly liquid investments that are both readily convertible to known amounts of cash, and so near their maturity that they present minimal risk of changes in value because of changes in interest rates. Generally, only investments with original maturities of three months or less qualify under that definition. Original maturity means original maturity to the entity holding the investment. For example, both a three-month US Treasury bill and a three-year Treasury note purchased three months from maturity qualify as cash equivalents. However, a Treasury note purchased three years ago does not become a cash equivalent when its remaining maturity is three months. Compensating balance arrangements that do not legally restrict the withdrawal or usage of cash amounts may be reported as Cash and Cash Equivalents, while legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or company statements of intention with regard to particular deposits are not generally reported as cash and cash equivalents. Includes cash and cash equivalents associated with the entity's continuing operations. Excludes cash and cash equivalents associated with the disposal group (and discontinued operation). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the aggregate carrying amount of all cost-method investments as reported on or included in the balance sheet. The original cost of the investments may differ from the aggregate carrying amount disclosed due to various adjustments such as: (i) dividends received in excess of earnings after the date of investment that are considered a return of investment and therefore recorded as reductions to cost of the investment, or (ii) a series of operating losses of an investee or other factors which may indicate that a decrease in value of the investment has occurred which is other than temporary and accordingly such decrease in value has been recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
For a classified balance sheet, the cumulative difference between the rental income or payments required by a lease agreement and the rental income or expense recognized on a straight-line basis, or other systematic and rational basis more representative of the time pattern in which use or benefit is granted or derived from the leased property, expected to be recognized in income or expense, by the lessor or lessee, respectively, more than one year after the balance sheet date. Such receivable is reduced by allowances attributable to, for instance, credit risk associated with a lessee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair values as of the balance sheet date of all assets resulting from contracts that meet the criteria of being accounted for as derivative instruments which are expected to exist longer than one year or beyond the normal operating cycle, if longer, net of the effects of master netting arrangements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Fair values as of the balance sheet date of all liabilities resulting from contracts that meet the criteria of being accounted for as derivative instruments, and which are expected to be extinguished or otherwise disposed of within a year or the normal operating cycle, if longer, net of the effects of master netting arrangements. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the carrying amount on the entity's balance sheet of its investment in common stock of an equity method investee. This is not an indicator of the fair value of the investment, rather it is the initial cost adjusted for the entity's share of earnings and losses of the investee, adjusted for any distributions (dividends) and other than temporary impairment (OTTI) losses recognized. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Gross carrying amount before accumulated amortization as of the balance sheet date of the costs pertaining to the exclusive legal rights granted to the owner of the patent to exploit an invention or a process for a period of time specified by law. Such costs may have been expended to directly apply and receive patent rights, or to acquire such rights. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Gross amount, at the balance sheet date, of long-lived, depreciable assets commonly used in offices and stores. Examples include desks, chairs, and store fixtures. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Gross amount, at the balance sheet date, of long-lived, depreciable assets that are an addition or improvement to assets held under lease arrangement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of all Liabilities and Stockholders' Equity items (or Partners' Capital, as applicable), including the portion of equity attributable to noncontrolling interests, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Total obligations incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Carrying value as of the balance sheet date of notes payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total debt and equity financial instruments including: (1) securities held-to-maturity, (2) trading securities, and (3) securities available-for-sale which are intended to be held for less than one year or the normal operating cycle, whichever is longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which is directly or indirectly attributable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
An amount representing an agreement for an unconditional promise by the maker to pay the Entity (holder) a definite sum of money at a future date more than one year from the balance sheet date, net of any write-downs taken for collection uncertainty on the part of the holder. Such amount may include accrued interest receivable in accordance with the terms of the debt. The debt also may contain provisions and related items including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among a myriad of other features and characteristics. This amount does not include amounts related to receivables held-for-sale. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Sum of the carrying values as of the balance sheet date of the portions of long-term notes payable due within one year or the operating cycle if longer. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Carrying amounts due as of the balance sheet date from parties or arising from transactions not otherwise specified in the taxonomy. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The total of the amounts paid in advance for capitalized costs that will be expensed with the passage of time or the occurrence of a triggering event, and will be charged against earnings within one year or the normal operating cycle, if longer, and the aggregate carrying amount of current assets, as of the balance sheet date, not separately presented elsewhere in the balance sheet. Current assets are expected to be realized or consumed within one year (or the normal operating cycle, if longer). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Gross amount, at the balance sheet date, of long-lived physical assets used in the normal conduct of business and not intended for resale. This can include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Tangible assets that are held by an entity for use in the production or supply of goods and services, for rental to others, or for administrative purposes and that are expected to provide economic benefit for more than one year; net of accumulated depreciation. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Amounts due from owners or affiliates of the reporting entity related to issuance of the entity's capital stock before cash payment is received (does not include amounts due from officers or directors). This element would also include the receivable for proceeds from the issuance of shares under employee stock option exercises which proceeds have not been received as of the reporting date due to the timing of the transaction date versus the settlement date. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cumulative amount of the reporting entity's undistributed earnings or deficit. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
|
Consolidated Balance Sheets (Parenthetical) (USD $)
|
Sep. 30, 2011
|
Sep. 30, 2010
|
|---|---|---|
| Consolidated Balance Sheets [Abstract] | ||
| Trade receivable, allowance for doubtful accounts | $ 90,789 | |
| Preferred stock, par value | $ 0.001 | $ 0.001 |
| Preferred stock, shares authorized | 5,000,000 | 5,000,000 |
| Preferred stock, shares issued | 0 | 0 |
| Preferred stock, shares outstanding | 0 | 0 |
| Common stock, par value | $ 0.001 | $ 0.001 |
| Common stock, shares authorized | 145,000,000 | 145,000,000 |
| Common stock, shares issued | 8,642,286 | 7,172,014 |
| Common stock, shares outstanding | 8,642,286 | 7,172,014 |
| X | ||||||||||
|
- Definition
A valuation allowance for trade and other receivables due to an Entity within one year (or the normal operating cycle, whichever is longer) that are expected to be uncollectible. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Face amount or stated value of common stock per share; generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of common shares permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total number of shares of common stock held by shareholders. May be all or portion of the number of common shares authorized. These shares represent the ownership interest of the common shareholders. Shares outstanding equals shares issued minus shares held in treasury and other adjustments, if any. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Face amount or stated value per share of nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer); generally not indicative of the fair market value per share. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Gain (loss) on entity's disposition of equity in securities of subsidiaries. Reflects the difference in the parent company's carrying amount of the equity interest in the subsidiary immediately before and after all stock transactions. No definition available.
|
| X | ||||||||||
|
- Definition
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Gain (loss) after tax expense or benefit, not previously recognized and resulting from the sale of a business component, which is recognized at the date of sale. A gain (loss) reflects the amount by which the consideration received exceeds (is exceeded by) the net carrying amount (reflecting previous provisions for loss on disposal, if any) of the disposal group. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
After tax income (loss) from operations of a business component (exclusive of any gain (loss) on disposal, or provision therefore) during the reporting period, until its disposal. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The difference between the sale price or salvage price and the book value of a property, plant, and equipment asset that was sold or retired during the reporting period. This element refers to the gain (loss). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses from ongoing operations, after income or loss from equity method investments, but before income taxes, extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the income or loss from continuing operations attributable to the economic entity which may also be defined as revenue less expenses and taxes from ongoing operations before extraordinary items, and noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) derived from continuing operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the overall income (loss) from a disposal group that is classified as a component of the entity, net of income tax, reported as a separate component of income before extraordinary items before deduction or consideration of the amount which may be allocable to noncontrolling interests, if any. Includes the following (net of tax): income (loss) from operations during the phase-out period, gain (loss) on disposal, provision (or any reversals of earlier provisions) for loss on disposal, and adjustments of a prior period gain (loss) on disposal. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income (loss) derived from discontinued operations during the period, net of related tax effect, per each share of common stock or unit outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The amount of net income or loss derived from discontinued operations during the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the entity's proportionate share for the period of the net income (loss) of its investee (such as unconsolidated subsidiaries and joint ventures) to which the equity method of accounting is applied. This item includes income or expense related to stock-based compensation based on the investor's grant of stock to employees of an equity method investee. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The sum of the current income tax expense or benefit and the deferred income tax expense or benefit pertaining to continuing operations. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net amount of operating interest income (expense). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of expenditures for salaries, wages, profit sharing and incentive compensation, and other employee benefits, including equity-based compensation, and pension and other postretirement benefit expense. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This item represents the net total realized and unrealized gain (loss) included in earnings for the period as a result of selling or holding marketable securities categorized as trading, available-for-sale, or held-to-maturity, including the unrealized holding gain (loss) of held-to-maturity securities transferred to the trading security category and the cumulative unrealized gain (loss) which was included in other comprehensive income (a separate component of shareholders' equity) for available-for-sale securities transferred to trading securities during the period. Additionally, this item would include any losses recognized for other than temporary impairments (OTTI) of the subject investments in debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of net Income or Loss attributable to the noncontrolling interest (if any) deducted in order to derive the portion attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense. No definition available.
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Definition
The net result for the period of deducting operating expenses from operating revenues. No definition available.
|
| X | ||||||||||
|
- Definition
Reflects the sum of all other revenue and income recognized by the entity in the period not otherwise specified in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Aggregate revenue recognized during the period (derived from goods sold, services rendered, insurance premiums, or other activities that constitute an entity's earning process). For financial services companies, also includes investment and interest income, and sales and trading gains. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Consolidated Statement Of Stockholders' Equity (USD $)
|
12 Months Ended | 101 Months Ended | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Sep. 30, 2011
|
Sep. 30, 2010
|
Sep. 30, 2009
|
Sep. 30, 2008
|
Sep. 30, 2007
|
Sep. 30, 2006
|
Sep. 30, 2005
|
Sep. 30, 2004
|
Sep. 30, 2003
|
Sep. 30, 2011
|
|
| Stock issued during period, value, new issues | $ 43,279 | $ 1,066,051 | $ 50,000 | $ (150,469) | ||||||
| Reclassification of former Unidym mezzanine debt to equity | 2,000,000 | |||||||||
| Stock issuance cost charged to additional paid-in capital | (991,318) | |||||||||
| Net loss attributable to Arrowhead | (3,492,399) | (6,957,038) | (19,308,392) | (27,241,639) | (30,712,947) | (19,961,961) | (6,733,427) | (751,255) | (95,238) | (131,542,282) |
| Stock issued during period, value, stock options exercised | 13,884 | 7,631 | 290,027 | 434,727 | 341,537 | 15,000 | ||||
| Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value | 1,404,640 | 1,582,149 | 2,676,170 | 3,187,397 | 2,175,544 | 1,369,478 | 508,513 | 175,653 | ||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | 300,000 | 16,297 | 1,720,962 | 230,087 | ||||||
| Issuance of preferred stock in subsidiary | 1,618,509 | 300,000 | ||||||||
| Amortization of discount on Unidym Series D Preferred Stock | ||||||||||
| Stockholders' equity, including portion attributable to noncontrolling interest, ending balance | 12,564,168 | 8,078,296 | 4,857,936 | 12,302,609 | 26,456,577 | 31,605,644 | 28,026,657 | 11,227,149 | 1,419,762 | 12,564,168 |
| Divestiture of Unidym | 254,275 | |||||||||
| Net loss attributable to Arrowhead | (3,128,885) | (5,774,048) | (113,707,792) | |||||||
|
Issued For Cash At $0.01 Per Unit [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $0.01 Per Unit [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 3,000 | |||||||||
| Stock issued during period, shares, new issues | 300,000 | |||||||||
|
Issued For Cash At $0.01 Per Unit [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $0.01 Per Unit [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $0.01 Per Unit [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $0.01 Per Unit [Member]
|
||||||||||
| Stock issued during period, value, new issues | 3,000 | |||||||||
|
Issued For Cash At $10.00 Per Unit [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $10.00 Per Unit [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 475 | 1,680 | ||||||||
| Stock issued during period, shares, new issues | 47,500 | 168,000 | ||||||||
|
Issued For Cash At $10.00 Per Unit [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 474,525 | 1,678,320 | ||||||||
|
Issued For Cash At $10.00 Per Unit [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $10.00 Per Unit [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $10.00 Per Unit [Member]
|
||||||||||
| Stock issued during period, value, new issues | 475,000 | 1,680,000 | ||||||||
|
Issued For Marketable Securities At $10.00 Per Unit [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Marketable Securities At $10.00 Per Unit [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 500 | |||||||||
| Stock issued during period, shares, new issues | 50,000 | |||||||||
|
Issued For Marketable Securities At $10.00 Per Unit [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 499,500 | |||||||||
|
Issued For Marketable Securities At $10.00 Per Unit [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Marketable Securities At $10.00 Per Unit [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Marketable Securities At $10.00 Per Unit [Member]
|
||||||||||
| Stock issued during period, value, new issues | 500,000 | |||||||||
|
Issued For Cash At $15.00 Per Unit [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $15.00 Per Unit [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 6,609 | |||||||||
| Stock issued during period, shares, new issues | 660,879 | |||||||||
|
Issued For Cash At $15.00 Per Unit [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 9,906,573 | |||||||||
|
Issued For Cash At $15.00 Per Unit [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $15.00 Per Unit [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Cash At $15.00 Per Unit [Member]
|
||||||||||
| Stock issued during period, value, new issues | 9,913,182 | |||||||||
|
Stock Issuance Cost Charged To Additional Paid In Capital [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
|
Stock Issuance Cost Charged To Additional Paid In Capital [Member] | Common Stock [Member]
|
||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
|
Stock Issuance Cost Charged To Additional Paid In Capital [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issuance cost charged to additional paid-in capital | (96,500) | (168,000) | ||||||||
|
Stock Issuance Cost Charged To Additional Paid In Capital [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
|
Stock Issuance Cost Charged To Additional Paid In Capital [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
|
Stock Issuance Cost Charged To Additional Paid In Capital [Member]
|
||||||||||
| Stock issuance cost charged to additional paid-in capital | (96,500) | (168,000) | ||||||||
|
Arrowheads Increase In Proportionate Share Of Insert Therapeutics Equity [Member] | Subscription Receivable [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Insert Therapeutics Equity [Member] | Common Stock [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Insert Therapeutics Equity [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | 2,401,394 | |||||||||
|
Arrowheads Increase In Proportionate Share Of Insert Therapeutics Equity [Member] | Retained Earnings [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Insert Therapeutics Equity [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Insert Therapeutics Equity [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | 2,401,394 | |||||||||
|
Arrowheads Increase In Proportionate Share Of Calando's Equity [Member] | Subscription Receivable [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Calando's Equity [Member] | Common Stock [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Calando's Equity [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | 2,120,250 | |||||||||
|
Arrowheads Increase In Proportionate Share Of Calando's Equity [Member] | Retained Earnings [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Calando's Equity [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
|
Arrowheads Increase In Proportionate Share Of Calando's Equity [Member]
|
||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | 2,120,250 | |||||||||
|
Issued as a Gift for $10.90 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued as a Gift for $10.90 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 163 | |||||||||
| Stock issued during period, shares, new issues | 15,000 | |||||||||
|
Issued as a Gift for $10.90 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 162,587 | |||||||||
|
Issued as a Gift for $10.90 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued as a Gift for $10.90 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued as a Gift for $10.90 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 162,750 | |||||||||
|
Issued As Stock Issuance Cost At $15.00 Per Unit [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued As Stock Issuance Cost At $15.00 Per Unit [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 356 | |||||||||
| Stock issued during period, shares, new issues | 35,623 | |||||||||
|
Issued As Stock Issuance Cost At $15.00 Per Unit [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 533,988 | |||||||||
|
Issued As Stock Issuance Cost At $15.00 Per Unit [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued As Stock Issuance Cost At $15.00 Per Unit [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued As Stock Issuance Cost At $15.00 Per Unit [Member]
|
||||||||||
| Stock issued during period, value, new issues | 534,344 | |||||||||
|
Exercised At $2.00 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, stock options exercised | ||||||||||
|
Exercised At $2.00 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, stock options exercised | 75 | |||||||||
| Stock issued during period, shares, stock options exercised | 7,500 | |||||||||
|
Exercised At $2.00 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, stock options exercised | 14,925 | |||||||||
|
Exercised At $2.00 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, stock options exercised | ||||||||||
|
Exercised At $2.00 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, stock options exercised | ||||||||||
|
Exercised At $2.00 Per Share [Member]
|
||||||||||
| Stock issued during period, value, stock options exercised | 15,000 | |||||||||
|
Exercised At $10.00 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
| Stock issued during period, value, stock options exercised | ||||||||||
|
Exercised At $10.00 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 25 | |||||||||
| Stock issued during period, shares, new issues | 2,500 | |||||||||
| Stock issued during period, value, stock options exercised | 6 | |||||||||
| Stock issued during period, shares, stock options exercised | 600 | |||||||||
|
Exercised At $10.00 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 24,975 | |||||||||
| Stock issued during period, value, stock options exercised | 5,994 | |||||||||
|
Exercised At $10.00 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
| Stock issued during period, value, stock options exercised | ||||||||||
|
Exercised At $10.00 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
| Stock issued during period, value, stock options exercised | ||||||||||
|
Exercised At $10.00 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 25,000 | |||||||||
| Stock issued during period, value, stock options exercised | 6,000 | |||||||||
|
Exercised At $15.00 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Exercised At $15.00 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 13,813 | |||||||||
| Stock issued during period, shares, new issues | 1,381,289 | |||||||||
|
Exercised At $15.00 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 20,705,522 | |||||||||
|
Exercised At $15.00 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Exercised At $15.00 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Exercised At $15.00 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 20,719,335 | |||||||||
|
Issued To Purchase Insert Therapeutics Share At $39.80 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Purchase Insert Therapeutics Share At $39.80 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 502 | |||||||||
| Stock issued during period, shares, new issues | 50,226 | |||||||||
|
Issued To Purchase Insert Therapeutics Share At $39.80 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,999,498 | |||||||||
|
Issued To Purchase Insert Therapeutics Share At $39.80 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Purchase Insert Therapeutics Share At $39.80 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Purchase Insert Therapeutics Share At $39.80 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 2,000,000 | |||||||||
|
Issued At $48.80 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $48.80 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 205 | |||||||||
| Stock issued during period, shares, new issues | 20,485 | |||||||||
|
Issued At $48.80 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 999,795 | |||||||||
|
Issued At $48.80 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $48.80 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $48.80 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,000,000 | |||||||||
|
Issued At $38.40 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $38.40 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 15 | |||||||||
| Stock issued during period, shares, new issues | 1,500 | |||||||||
|
Issued At $38.40 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 57,585 | |||||||||
|
Issued At $38.40 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $38.40 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $38.40 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 57,600 | |||||||||
|
Issued At $35.00 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $35.00 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 5,590 | |||||||||
| Stock issued during period, shares, new issues | 559,000 | |||||||||
|
Issued At $35.00 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 19,539,410 | |||||||||
|
Issued At $35.00 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $35.00 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $35.00 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 19,545,000 | |||||||||
|
Issued At $59.10 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $59.10 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 25 | |||||||||
| Stock issued during period, shares, new issues | 2,536 | |||||||||
|
Issued At $59.10 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 149,975 | |||||||||
|
Issued At $59.10 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $59.10 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $59.10 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 150,000 | |||||||||
|
Issued To Purchase Calando Pharmaceuticals Inc At $51.70 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Purchase Calando Pharmaceuticals Inc At $51.70 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 208 | |||||||||
| Stock issued during period, shares, new issues | 20,838 | |||||||||
|
Issued To Purchase Calando Pharmaceuticals Inc At $51.70 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,077,125 | |||||||||
|
Issued To Purchase Calando Pharmaceuticals Inc At $51.70 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Purchase Calando Pharmaceuticals Inc At $51.70 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Purchase Calando Pharmaceuticals Inc At $51.70 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,077,333 | |||||||||
|
Issued At $57.80 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $57.80 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 2,849 | |||||||||
| Stock issued during period, shares, new issues | 284,945 | |||||||||
|
Issued At $57.80 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 15,149,366 | |||||||||
|
Issued At $57.80 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $57.80 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $57.80 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 15,152,215 | |||||||||
|
Issued For Purchase Of Carbon Nanotechnologies Inc At $37.70 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Purchase Of Carbon Nanotechnologies Inc At $37.70 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,431 | |||||||||
| Stock issued during period, shares, new issues | 143,122 | |||||||||
|
Issued For Purchase Of Carbon Nanotechnologies Inc At $37.70 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 5,398,569 | |||||||||
|
Issued For Purchase Of Carbon Nanotechnologies Inc At $37.70 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Purchase Of Carbon Nanotechnologies Inc At $37.70 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued For Purchase Of Carbon Nanotechnologies Inc At $37.70 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 5,400,000 | |||||||||
|
Issued At Approximately $18.00 Per Share Net [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At Approximately $18.00 Per Share Net [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 3,867 | |||||||||
| Stock issued during period, shares, new issues | 386,399 | |||||||||
|
Issued At Approximately $18.00 Per Share Net [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 6,956,718 | |||||||||
|
Issued At Approximately $18.00 Per Share Net [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At Approximately $18.00 Per Share Net [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At Approximately $18.00 Per Share Net [Member]
|
||||||||||
| Stock issued during period, value, new issues | 6,960,585 | |||||||||
|
Issued At $27.20 Per Share To Rice University [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $27.20 Per Share To Rice University [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 50 | |||||||||
| Stock issued during period, shares, new issues | 5,000 | |||||||||
|
Issued At $27.20 Per Share To Rice University [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 135,950 | |||||||||
|
Issued At $27.20 Per Share To Rice University [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $27.20 Per Share To Rice University [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $27.20 Per Share To Rice University [Member]
|
||||||||||
| Stock issued during period, value, new issues | 136,000 | |||||||||
|
Issued At $28.30 Per Share To Purchase Shares Of Unidym Inc [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $28.30 Per Share To Purchase Shares Of Unidym Inc [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 71 | |||||||||
| Stock issued during period, shares, new issues | 7,055 | |||||||||
|
Issued At $28.30 Per Share To Purchase Shares Of Unidym Inc [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 199,929 | |||||||||
|
Issued At $28.30 Per Share To Purchase Shares Of Unidym Inc [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $28.30 Per Share To Purchase Shares Of Unidym Inc [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $28.30 Per Share To Purchase Shares Of Unidym Inc [Member]
|
||||||||||
| Stock issued during period, value, new issues | 200,000 | |||||||||
|
Issued At $29.50 per Share To Purchase MASA Energy LLC [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $29.50 per Share To Purchase MASA Energy LLC [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 105 | |||||||||
| Stock issued during period, shares, new issues | 10,505 | |||||||||
|
Issued At $29.50 per Share To Purchase MASA Energy LLC [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 309,895 | |||||||||
|
Issued At $29.50 per Share To Purchase MASA Energy LLC [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $29.50 per Share To Purchase MASA Energy LLC [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $29.50 per Share To Purchase MASA Energy LLC [Member]
|
||||||||||
| Stock issued during period, value, new issues | 310,000 | |||||||||
|
Issued At $21.90 Per Share To Unidym For The Acquisition Of Nanoconduction [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $21.90 Per Share To Unidym For The Acquisition Of Nanoconduction [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 114 | |||||||||
| Stock issued during period, shares, new issues | 11,416 | |||||||||
|
Issued At $21.90 Per Share To Unidym For The Acquisition Of Nanoconduction [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 249,886 | |||||||||
|
Issued At $21.90 Per Share To Unidym For The Acquisition Of Nanoconduction [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $21.90 Per Share To Unidym For The Acquisition Of Nanoconduction [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $21.90 Per Share To Unidym For The Acquisition Of Nanoconduction [Member]
|
||||||||||
| Stock issued during period, value, new issues | 250,000 | |||||||||
|
Issued At $21.80 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $21.80 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 15 | |||||||||
| Stock issued during period, shares, new issues | 1,500 | |||||||||
|
Issued At $21.80 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 32,685 | |||||||||
|
Issued At $21.80 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $21.80 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $21.80 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 32,700 | |||||||||
|
Issued At $5.50 Per Share To Unidym Stockholder In Exchange For Unidym's Shares [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $5.50 Per Share To Unidym Stockholder In Exchange For Unidym's Shares [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 2,059 | |||||||||
| Stock issued during period, shares, new issues | 205,839 | |||||||||
|
Issued At $5.50 Per Share To Unidym Stockholder In Exchange For Unidym's Shares [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,131,617 | |||||||||
|
Issued At $5.50 Per Share To Unidym Stockholder In Exchange For Unidym's Shares [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $5.50 Per Share To Unidym Stockholder In Exchange For Unidym's Shares [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $5.50 Per Share To Unidym Stockholder In Exchange For Unidym's Shares [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,133,676 | |||||||||
|
Issued At $5.20 Per Share To TEL Ventures In Exchange For Unidym's Shares [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $5.20 Per Share To TEL Ventures In Exchange For Unidym's Shares [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 2,222 | |||||||||
| Stock issued during period, shares, new issues | 222,222 | |||||||||
|
Issued At $5.20 Per Share To TEL Ventures In Exchange For Unidym's Shares [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,156,111 | |||||||||
|
Issued At $5.20 Per Share To TEL Ventures In Exchange For Unidym's Shares [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $5.20 Per Share To TEL Ventures In Exchange For Unidym's Shares [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $5.20 Per Share To TEL Ventures In Exchange For Unidym's Shares [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,158,333 | |||||||||
|
Issued At $3.00 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $3.00 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 9,197 | |||||||||
| Stock issued during period, shares, new issues | 919,664 | |||||||||
|
Issued At $3.00 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 2,749,796 | |||||||||
|
Issued At $3.00 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $3.00 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $3.00 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 2,758,993 | |||||||||
|
Issued At $6.30 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $6.30 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 5,083 | |||||||||
| Stock issued during period, shares, new issues | 508,343 | |||||||||
|
Issued At $6.30 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 3,217,813 | |||||||||
|
Issued At $6.30 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $6.30 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $6.30 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 3,222,896 | |||||||||
|
Issued At $13.12 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $13.12 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 6,593 | |||||||||
| Stock issued during period, shares, new issues | 659,299 | |||||||||
|
Issued At $13.12 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 3,692,078 | |||||||||
|
Issued At $13.12 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $13.12 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $13.12 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 3,698,671 | |||||||||
|
Issued At $3.80 Per Share [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $3.80 Per Share [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 14,574 | |||||||||
| Stock issued during period, shares, new issues | 1,458,917 | |||||||||
|
Issued At $3.80 Per Share [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 4,629,110 | |||||||||
|
Issued At $3.80 Per Share [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $3.80 Per Share [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued At $3.80 Per Share [Member]
|
||||||||||
| Stock issued during period, value, new issues | 4,643,684 | |||||||||
|
Issuance Of Common Stock For Subscription [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | (900,000) | |||||||||
|
Issuance Of Common Stock For Subscription [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
| Stock issued during period, shares, new issues | ||||||||||
|
Issuance Of Common Stock For Subscription [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 900,000 | |||||||||
|
Issuance Of Common Stock For Subscription [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issuance Of Common Stock For Subscription [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issuance Of Common Stock For Subscription [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Series D Preferred Stock Issued For Subscription In Unidym [Member] | Subscription Receivable [Member]
|
||||||||||
| Issuance of preferred stock in subsidiary | (300,000) | |||||||||
|
Series D Preferred Stock Issued For Subscription In Unidym [Member] | Common Stock [Member]
|
||||||||||
| Issuance of preferred stock in subsidiary | ||||||||||
|
Series D Preferred Stock Issued For Subscription In Unidym [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Issuance of preferred stock in subsidiary | 300,000 | |||||||||
|
Series D Preferred Stock Issued For Subscription In Unidym [Member] | Retained Earnings [Member]
|
||||||||||
| Issuance of preferred stock in subsidiary | ||||||||||
|
Series D Preferred Stock Issued For Subscription In Unidym [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Issuance of preferred stock in subsidiary | ||||||||||
|
Series D Preferred Stock Issued For Subscription In Unidym [Member]
|
||||||||||
| Issuance of preferred stock in subsidiary | ||||||||||
|
Issued To Unidym Stockholders In Exchange For Unidym's Shares [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Unidym Stockholders In Exchange For Unidym's Shares [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 153 | |||||||||
| Stock issued during period, shares, new issues | 15,318 | |||||||||
|
Issued To Unidym Stockholders In Exchange For Unidym's Shares [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | (1,435) | |||||||||
|
Issued To Unidym Stockholders In Exchange For Unidym's Shares [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Unidym Stockholders In Exchange For Unidym's Shares [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,282 | |||||||||
|
Issued To Unidym Stockholders In Exchange For Unidym's Shares [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Calando Stockholders In Exchange For Calando's Shares [Member] | Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Calando Stockholders In Exchange For Calando's Shares [Member] | Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 1,220 | |||||||||
| Stock issued during period, shares, new issues | 122,000 | |||||||||
|
Issued To Calando Stockholders In Exchange For Calando's Shares [Member] | Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | (160,667) | |||||||||
|
Issued To Calando Stockholders In Exchange For Calando's Shares [Member] | Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Issued To Calando Stockholders In Exchange For Calando's Shares [Member] | Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | 159,447 | |||||||||
|
Issued To Calando Stockholders In Exchange For Calando's Shares [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
|
Subscription Receivable [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
| Reclassification of former Unidym mezzanine debt to equity | ||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
| Net loss attributable to Arrowhead | ||||||||||
| Stock issued during period, value, stock options exercised | ||||||||||
| Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value | ||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
| Issuance of preferred stock in subsidiary | 300,000 | |||||||||
| Amortization of discount on Unidym Series D Preferred Stock | ||||||||||
| Stockholders' equity, including portion attributable to noncontrolling interest, ending balance | (900,000) | (300,000) | (900,000) | |||||||
| Divestiture of Unidym | ||||||||||
|
Common Stock [Member]
|
||||||||||
| Stock issued during period, value, new issues | 87 | 2,251 | 12 | 706 | ||||||
| Stock issued during period, shares, new issues | 8,656 | 225,189 | 1,250 | 70,553 | ||||||
| Reclassification of former Unidym mezzanine debt to equity | ||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
| Net loss attributable to Arrowhead | ||||||||||
| Stock issued during period, value, stock options exercised | 27 | 7 | 106 | 186 | 116 | 75 | ||||
| Stock issued during period, shares, stock options exercised | 2,700 | 688 | 10,536 | 18,616 | 11,579 | 7,500 | ||||
| Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value | ||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
| Issuance of preferred stock in subsidiary | ||||||||||
| Amortization of discount on Unidym Series D Preferred Stock | ||||||||||
| Stockholders' equity, including portion attributable to noncontrolling interest, ending balance | 86,423 | 71,735 | 56,428 | 42,950 | 38,622 | 34,156 | 27,997 | 13,645 | 4,680 | 86,423 |
| Shares, issued | 8,642,286 | 7,172,014 | 5,641,177 | 4,293,452 | 3,861,042 | 3,414,359 | 2,798,419 | 1,363,155 | 468,000 | 8,642,286 |
| Divestiture of Unidym | ||||||||||
|
Additional Paid-In Capital [Member]
|
||||||||||
| Stock issued during period, value, new issues | 43,192 | 1,063,600 | 49,988 | (151,175) | ||||||
| Reclassification of former Unidym mezzanine debt to equity | 2,000,000 | |||||||||
| Stock issuance cost charged to additional paid-in capital | (991,318) | |||||||||
| Net loss attributable to Arrowhead | ||||||||||
| Stock issued during period, value, stock options exercised | 13,857 | 7,624 | 289,921 | 434,541 | 341,421 | 14,925 | ||||
| Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value | 1,404,640 | 1,582,149 | 2,676,170 | 3,187,397 | 2,175,544 | 1,369,478 | 508,513 | 175,653 | ||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | (849,707) | 245,345 | 16,297 | 1,720,962 | 230,087 | |||||
| Issuance of preferred stock in subsidiary | 1,618,509 | |||||||||
| Amortization of discount on Unidym Series D Preferred Stock | 163,960 | |||||||||
| Stockholders' equity, including portion attributable to noncontrolling interest, ending balance | 127,476,435 | 119,716,834 | 110,070,327 | 97,756,126 | 84,672,783 | 59,113,369 | 35,578,580 | 12,059,997 | 1,510,320 | 127,476,435 |
| Divestiture of Unidym | ||||||||||
|
Retained Earnings [Member]
|
||||||||||
| Stock issued during period, value, new issues | ||||||||||
| Reclassification of former Unidym mezzanine debt to equity | ||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
| Net loss attributable to Arrowhead | (3,128,885) | (5,774,048) | (19,308,392) | (27,089,030) | (29,931,118) | (18,997,209) | (6,854,918) | (2,528,954) | (95,238) | |
| Stock issued during period, value, stock options exercised | ||||||||||
| Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value | ||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | ||||||||||
| Issuance of preferred stock in subsidiary | ||||||||||
| Amortization of discount on Unidym Series D Preferred Stock | (163,960) | |||||||||
| Stockholders' equity, including portion attributable to noncontrolling interest, ending balance | (113,871,752) | (110,742,867) | (104,968,819) | (85,496,467) | (58,407,437) | (28,476,319) | (9,479,110) | (2,624,192) | (95,238) | (113,871,752) |
| Divestiture of Unidym | ||||||||||
|
Noncontrolling Interest [Member]
|
||||||||||
| Stock issued during period, value, new issues | 200 | |||||||||
| Reclassification of former Unidym mezzanine debt to equity | ||||||||||
| Stock issuance cost charged to additional paid-in capital | ||||||||||
| Net loss attributable to Arrowhead | (363,514) | (1,182,990) | (152,609) | (781,829) | (964,752) | 121,491 | 1,777,699 | |||
| Stock issued during period, value, stock options exercised | ||||||||||
| Adjustments to additional paid in capital, share-based compensation, requisite service period recognition, value | ||||||||||
| Adjustments to additional paid in capital, reallocation of noncontrolling interest | 849,707 | 54,655 | ||||||||
| Issuance of preferred stock in subsidiary | ||||||||||
| Amortization of discount on Unidym Series D Preferred Stock | ||||||||||
| Stockholders' equity, including portion attributable to noncontrolling interest, ending balance | (226,938) | (967,406) | 152,609 | 934,438 | 1,899,190 | 1,777,699 | (226,938) | |||
| Divestiture of Unidym | $ 254,275 | |||||||||
| X | ||||||||||
|
- Definition
Adjustment to Additional Paid in Capital resulting from the recognition of deferred taxes for the temporary difference of the convertible debt with a beneficial conversion feature. A beneficial conversion feature is a nondetachable conversion feature that is in-the-money. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Adjustment to additional paid in capital resulting from the recognition of convertible debt instruments as two separate components - a debt component and an equity component. This bifurcation may result in a basis difference associated with the liability component that represents a temporary difference for purposes of applying accounting for income taxes. The initial recognition of deferred taxes for the tax effect of that temporary difference is as an adjustment to additional paid in capital. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Change in additional paid in capital as a result of a reallocation of a subsidiary's stockholders' equity to noncontrolling interest due to the subsidiary issuing stock. This reallocation is from a capital transaction. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents the amount of recognized equity-based compensation during the period, that is, the amount recognized as expense in the income statement (or as asset if compensation is capitalized). Alternate captions include the words "stock-based compensation". Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Direct costs (e.g., legal and accounting fees) associated with issuing stock that is deducted from additional paid in capital. Also includes any direct costs associated with stock issues under a shelf registration. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Represents an increase in noncontrolling interest from issuance of additional equity interests to noncontrolling interest holders or the sale of a portion of the parent's controlling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Proceeds from issuance of capital stock which provides for a specific dividend that is paid to the shareholders before any dividends to common stockholders and which takes precedence over common stockholders in the event of liquidation. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Total of Stockholders' Equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity including portions attributable to both the parent and noncontrolling interests (previously referred to as minority interest), if any. The entity including portions attributable to the parent and noncontrolling interests is sometimes referred to as the economic entity. This excludes temporary equity and is sometimes called permanent equity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Value stock issued during the period as a result of the exercise of stock options. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
|
Consolidated Statement Of Stockholders' Equity (Parenthetical) (USD $)
|
Sep. 30, 2003
Issued For Cash At $0.01 Per Unit [Member]
|
Sep. 30, 2004
Issued For Cash At $10.00 Per Unit [Member]
|
Sep. 30, 2003
Issued For Cash At $10.00 Per Unit [Member]
|
Sep. 30, 2004
Issued For Marketable Securities At $10.00 Per Unit [Member]
|
Sep. 30, 2004
Issued For Cash At $15.00 Per Unit [Member]
|
Sep. 30, 2004
Issued as a Gift for $10.90 Per Share [Member]
|
Sep. 30, 2004
Issued As Stock Issuance Cost At $15.00 Per Unit [Member]
|
Sep. 30, 2004
Exercised At $2.00 Per Share [Member]
|
Sep. 30, 2005
Exercised At $10.00 Per Share [Member]
|
Sep. 30, 2004
Exercised At $10.00 Per Share [Member]
|
Sep. 30, 2005
Exercised At $15.00 Per Share [Member]
|
Sep. 30, 2006
Issued At $48.80 Per Share [Member]
|
Sep. 30, 2005
Issued To Purchase Insert Therapeutics Share At $39.80 Per Share [Member]
|
Sep. 30, 2006
Issued At $38.40 Per Share [Member]
|
Sep. 30, 2006
Issued At $35.00 Per Share [Member]
|
Sep. 30, 2006
Issued At $59.10 Per Share [Member]
|
Sep. 30, 2006
Issued To Purchase Calando Pharmaceuticals Inc At $51.70 Per Share [Member]
|
Sep. 30, 2007
Issued At $57.80 Per Share [Member]
|
Sep. 30, 2007
Issued For Purchase Of Carbon Nanotechnologies Inc At $37.70 Per Share [Member]
|
Sep. 30, 2008
Issued At Approximately $18.00 Per Share Net [Member]
|
Sep. 30, 2008
Issued At $27.20 Per Share To Rice University [Member]
|
Sep. 30, 2008
Issued At $28.30 Per Share To Purchase Shares Of Unidym Inc [Member]
|
Sep. 30, 2008
Issued At $29.50 per Share To Purchase MASA Energy LLC [Member]
|
Sep. 30, 2008
Issued At $21.90 Per Share To Unidym For The Acquisition Of Nanoconduction [Member]
|
Sep. 30, 2008
Issued At $21.80 Per Share [Member]
|
Sep. 30, 2009
Issued At $5.50 Per Share To Unidym Stockholder In Exchange For Unidym's Shares [Member]
|
Sep. 30, 2009
Issued At $5.20 Per Share To TEL Ventures In Exchange For Unidym's Shares [Member]
|
Sep. 30, 2009
Issued At $3.00 Per Share [Member]
|
Sep. 30, 2010
Issued At $6.30 Per Share [Member]
|
Sep. 30, 2010
Issued At $13.12 Per Share [Member]
|
Sep. 30, 2011
Issued At $3.80 Per Share [Member]
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common stock & warrants issued for cash, price per unit | $ 0.01 | $ 10 | $ 10 | $ 10 | $ 15 | $ 10.9 | $ 15 | ||||||||||||||||||||||||
| Exercise of stock options, price per share | $ 2 | $ 10 | $ 10 | $ 15 |